NCT06398522

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome: a Randomized Double-blind Placebo-controlled Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: University of Bologna · Academic / Other
• Sex: All
• Age: 40 Years – 75 Years
• Healthy volunteers: Accepted

Summary

This was a double-blind, randomized, placebo-controlled clinical study aiming to assess the effect of a food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3 on liver steatosis in individuals with NAFLD and metabolic syndrome

Conditions

• NAFLD
• Metabolic Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Food for special medical purposes with calcium butyrate, zinc gluconate and vitamin D3	Food for special medical purposes with functional release containing calcium butyrate, zinc gluconate and vitamin D3
OTHER	Placebo	Placebo

Timeline

• Start date: 2017-03-01
• Primary completion: 2018-06-01
• Completion: 2018-06-01
• First posted: 2024-05-03
• Last updated: 2024-05-03

Locations

1 site across 1 country: Italy